Correlation Between Enorama Pharma and Scandinavian ChemoTech
Specify exactly 2 symbols:
By analyzing existing cross correlation between Enorama Pharma AB and Scandinavian ChemoTech AB, you can compare the effects of market volatilities on Enorama Pharma and Scandinavian ChemoTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enorama Pharma with a short position of Scandinavian ChemoTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enorama Pharma and Scandinavian ChemoTech.
Diversification Opportunities for Enorama Pharma and Scandinavian ChemoTech
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Enorama and Scandinavian is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Enorama Pharma AB and Scandinavian ChemoTech AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scandinavian ChemoTech and Enorama Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enorama Pharma AB are associated (or correlated) with Scandinavian ChemoTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scandinavian ChemoTech has no effect on the direction of Enorama Pharma i.e., Enorama Pharma and Scandinavian ChemoTech go up and down completely randomly.
Pair Corralation between Enorama Pharma and Scandinavian ChemoTech
Assuming the 90 days trading horizon Enorama Pharma AB is expected to generate 1.36 times more return on investment than Scandinavian ChemoTech. However, Enorama Pharma is 1.36 times more volatile than Scandinavian ChemoTech AB. It trades about 0.03 of its potential returns per unit of risk. Scandinavian ChemoTech AB is currently generating about -0.01 per unit of risk. If you would invest 412.00 in Enorama Pharma AB on September 3, 2024 and sell it today you would lose (66.00) from holding Enorama Pharma AB or give up 16.02% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enorama Pharma AB vs. Scandinavian ChemoTech AB
Performance |
| Timeline |
| Enorama Pharma AB |
| Scandinavian ChemoTech |
Enorama Pharma and Scandinavian ChemoTech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enorama Pharma and Scandinavian ChemoTech
The main advantage of trading using opposite Enorama Pharma and Scandinavian ChemoTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enorama Pharma position performs unexpectedly, Scandinavian ChemoTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scandinavian ChemoTech will offset losses from the drop in Scandinavian ChemoTech's long position.| Enorama Pharma vs. Cantargia AB | Enorama Pharma vs. Enzymatica publ AB | Enorama Pharma vs. Lidds AB | Enorama Pharma vs. BioArctic AB |
| Scandinavian ChemoTech vs. Vicore Pharma Holding | Scandinavian ChemoTech vs. Enorama Pharma AB | Scandinavian ChemoTech vs. Xintela AB | Scandinavian ChemoTech vs. Alzinova AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets |